Fentanyl Pectin Nasal Spray Effective in Clinical Study
Links shared publicly online about this topic.
- 825total visits
Fentanyl Pectin Nasal Spray Effective in Clinical Study
View full resource at hcplive.com
Tags: Pain, Cancer, Cancer Pain Medication, Nose, Duragesic, Actiq
Most Recently Shared on October 4, 2010 at 9:30 pm By:
Fentanyl Pectin Nasal Spray Effective in Clinical Study http://hcp.lv/bmglWL
Archimedes publishes results from FPNS Phase III clinical study for breakthrough cancer pain
news-medical.net — “Archimedes Pharma, an emerging specialty pharma company focused on oncology, pain, neurology and critical care sectors, today announced publication of results from a Phase III, long-term safety, tolerability and consistency of effect, clinical study of fentanyl pectin nasal spray (FPNS) in the treatment of breakthrough cancer pain (BTCP).” View full resource at news-medical.net
Most Recently Shared on October 13, 2010 at 7:11 am By:
Archimedes publishes results from FPNS Phase III clinical study for breakthrough cancer pain: Archimedes Pharma, a... http://bit.ly/9je4f9
Archimedes Pharma Announces Publication of Long-Term Safety and Tolerability Clinical Study of Fentanyl Pectin Nasal Spray (FPNS) in the Journal of Opioid Management - Drugs.com MedNews
drugs.com — “Archimedes Pharma, an emerging specialty pharma company focused on oncology, pain, neurology and critical care sectors, today announced publication of results f” View full resource at drugs.com
Most Recently Shared on October 12, 2010 at 8:08 pm By:
Drugs and Devices OW OW Health
Archimedes Pharma Announces Publication of Long-Term Safety and Tolerability Clinical Study of Fentanyl Pecti... http://bit.ly/cSLw5T #drug
Archimedes publishes FPNS clinical study results in Pain journal
news-medical.net — “Archimedes Pharma US Inc. today announced publication of results from a pivotal clinical study of Fentanyl Pectin Nasal Spray (FPNS) in the treatment of breakthrough cancer pain (BTCP).” View full resource at news-medical.net
Most Recently Shared on October 5, 2010 at 4:05 pm By:
News-Medical.Net Health News and Oncology
Oncology News: Archimedes publishes FPNS clinical study results in Pain journal: Archimedes Pharma US Inc. today a... http://bit.ly/cg07ON
Archimedes Pharma Announces Publication of a Pivotal Clinical Study of Fentanyl Pectin Nasal Spray (FPNS) in Pain, the Peer-Reviewed Journal from the International Association for the Study of Pain - Drugs.com MedNews
drugs.com — “BEDMINSTER, N.J., Archimedes Pharma US Inc. today announced publication of results from a pivotal clinical study of Fentanyl Pectin Nasal Spray (FPNS) in the tr” View full resource at drugs.com
Most Recently Shared on October 4, 2010 at 12:10 pm By:
Drugs and Devices OW OW Health
Archimedes Pharma Announces Publication of a Pivotal Clinical Study of Fentanyl Pectin Nasal Spray (FPNS) in ... http://bit.ly/aLm4bU #drug
Advertisement
